Evidence map›Paper›PMID 42756534›Full record

ArticleFrontiers in cell and developmental biology2026

A novel frameshift variant in

Lingyi Li, Feng Wan, Ke Feng, Xiaowei Qu, Yanqing Xia, Jianjun Dong, Yilin Liu, Yanbing Zhao, Guangli Zhu, Baona Yin and 1 more

Abstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Lingyi Li *Department of Reproductive Medicine Center, Henan Provincial People's Hospital, Zhengzhou, Henan, China.
Feng Wan *Department of Reproductive Medicine Center, Henan Provincial People's Hospital, Zhengzhou, Henan, China.
Ke FengDepartment of Reproductive Medicine Center, Henan Provincial People's Hospital, Zhengzhou, Henan, China.
Xiaowei QuDepartment of Reproductive Medicine Center, Henan Provincial People's Hospital, Zhengzhou, Henan, China.
Yanqing XiaDepartment of Reproductive Medicine Center, Henan Provincial People's Hospital, Zhengzhou, Henan, China.
Jianjun DongDepartment of Andrology, Jiaozuo Maternal and Child Health Hospital, Jiaozuo, Henan, China.
Yilin LiuDepartment of Andrology, Jiaozuo Maternal and Child Health Hospital, Jiaozuo, Henan, China.
Yanbing ZhaoDepartment of Reproductive Medicine Center, Jiaozuo Maternal and Child Health Hospital, Jiaozuo, Henan, China.
Guangli ZhuDepartment of Reproductive Medicine Center, Jiaozuo Maternal and Child Health Hospital, Jiaozuo, Henan, China.
Baona YinDepartment of Reproductive Medicine Center, Jiaozuo Maternal and Child Health Hospital, Jiaozuo, Henan, China.
Haibin GuoDepartment of Reproductive Medicine Center, Henan Provincial People's Hospital, Zhengzhou, Henan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Severe sperm motility defects are an important cause of male infertility and are frequently associated with sperm flagellar abnormalities. Methods: A Chinese man with total asthenozoospermia was investigated using whole-exome sequencing, Sanger sequencing, transmission electron microscopy, sperm immunofluorescence, and heterologous expression analysis in HEK293 T cells. The clinical outcome following intracytoplasmic sperm injection (ICSI) was also evaluated. Results: Whole-exome sequencing identified a novel Conclusion: We identified a novel

Indexed as

frameshift variantmale infertilitymultiple morphological abnormalities of the sperm flagellatotal asthenozoospermiaTTC29

Identifiers

PMID42756534
PMCPMC13583038

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.